Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human immunodeficiency virus 1

ABSTRACT: HIV-1 V3-loop 454 sequencing to define virus tropism

PROVIDER: PRJNA188778 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR698770.fastq.gz	Fastqsanger.gz
	SRR698794.fastq.gz	Fastqsanger.gz
	SRR698868.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Human immunodeficiency virus 1

Project description:HIV-1 tropism determination Using NGS

| PRJDB3249 | ENA

Human immunodeficiency virus 1 strain:1

Project description:HIV PCR bias sequencing on 454 (Pilot)

| PRJNA30455 | ENA

Human immunodeficiency virus-1 targets genomic R-loops of the host for integration [DRIPc]

Project description:Although HIV-1 integration sites are considered to favor active transcription units in the human genome, high-resolution analysis of individual HIV-1 integration sites have shown that the virus can integrate in a variety of host genomic locations, including non-genic regions, challenging the traditional understanding of HIV-1 integration site selection. Here, we showed that HIV-1 targets R-loops, a genomic structure made up of DNA–RNA hybrids, for integration. HIV-1 initiates the formation of R-loops in both genic and non-genic regions of the host genome and preferentially integrates into regions of HIV-1-induced R-loops. Using a cell model that can independently control transcriptional activity and R-loop formation, we demonstrated that the presence of R-loops, regardless of transcriptional activity, directs HIV-1 integration targeting sites. We also found that HIV-1 integrase proteins bind to the host genomic R-loops. These findings provide fundamental insights into the mechanisms of retroviral integration and the new strategies of antiretroviral therapy against HIV-1 latent infection.

2024-11-05 | GSE281025 | GEO

Human immunodeficiency virus-1 targets genomic R-loops of the host for integration [RNA-seq]

2024-11-05 | GSE281027 | GEO

Human immunodeficiency virus-1 targets genomic R-loops of the host for integration [IS-seq]

2024-11-05 | GSE281026 | GEO

Human immunodeficiency virus 1

Project description:Full-length sequencing of a heterogeneous five HIV-1 virus mixture

| PRJNA217811 | ENA

Human immunodeficiency virus

Project description:Comparison of HIV-1 and HIV-2 Mutagenesis by Illumina Sequencing

| PRJNA287455 | ENA

Fetal Metabolic Stress Disrupts Immune Homeostasis and Induces Proinflammatory Responses in Human Immunodeficiency Virus Type 1- and Combination Antiretroviral Therapy-Exposed Infants

Project description:Increased morbidity and fetal growth restriction are reported in uninfected children born to human immunodeficiency virus type 1 (HIV-1)–infected women treated with antiretroviral (ARV) therapy. Viruses and/or pharmacological interventions such as ARVs can induce metabolic stress, skewing the cell’s immune response and restricting (cell) growth. Novel metabolomic techniques provided the opportunity to investigate the impact of fetal HIV-1 and combination ARV therapy (cART) exposure on the infants’ immune metabolome. Peroxidized lipids, generated by reactive oxygen species, were increased in cART/HIV-1–exposed infants, indicating altered mitochondrial functioning. The lipid metabolism was further dysregulated with increased triglyceride species and a subsequent decrease in phospholipids in cART/HIV-1–exposed infants compared to control infants. Proinflammatory immune mediators, lysophospholipids as well as cytokines such as CXCL10 and CCL3, were increased whereas anti-inflammatory metabolites from the cytochrome P450 pathway were reduced in cART/HIV-1–exposed infants. Taken together, these data demonstrate that the fetal metabolism is impacted by maternal factors (cART and HIV-1) and skews physiological immune responses toward inflammation in the newborn infant.

2018-06-06 | MTBLS449 | MetaboLights

Human immunodeficiency virus 1

Project description:HIV-1 genome sequencing, genetic analysis of HIV-1 recombinant forms

| PRJDB13369 | ENA

Human immunodeficiency virus 1

Project description:HIV-1 quasispecies analysis

| PRJDB3502 | ENA